Table 1 Patients’ characteristics and operative data
Mean age (range) | 67.7 (48–76) |
|---|---|
Mean BMI (kg/m2), (range) | 23.7 (16.6–33.2) |
Mean preoperative PSA (ng/mL), (range) | 9.21 (2.24–43.20) |
Clinical T stage, (%) | |
T1b | 3 (1.5) |
T1c | 122 (60.1) |
T2a | 45 (22.1) |
T2b | 15 (7.4) |
T2c | 18 (8.9) |
D’Amico Risk Criteria, (%) | |
Low risk | 40 (19.7) |
Intermediate risk | 108 (53.2) |
High risk | 55 (27.1) |
Operation procedure, (%) | |
Laparoscopic | 99 (48.8) |
Robot-assisted | 104 (51.2) |
Nerve-sparing, (%) | |
Bilateral | 24 (11.8) |
Unilateral | 61 (30.0) |
Non-sparing | 118 (58.1) |
Mean operative time (min), (range) | 257 (137–612) |
Mean estimated blood loss (g), (range) | 378 (10–2431) |
Mean prostate volume (mL), (range) | 41 (18–92) |
Positive surgical margin, (%) | 56 (27.5) |
Vesicourethral anastomosis leakage, (%) | 16 (7.9) |
Mean Postoperative followup (days) | 1131 (79–2880) |